Saniona publicerar sin delårsrapport för det första kvartalet 2021

NEXT STORY
Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available
PREV STORY
OSE Immunotherapeutics Announces Dosing of the First Healthy Volunteer in Phase 1 Clinical Trial of its Multi-Variant Second-Generation COVID-19 Vaccine
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Luigi Franciosi to Advise on New Asthma & COPD Drug Development Programs for Vicenna Pharmaceuticals Inc.

author_avatar
NASDAQ Market News

Vaccinex, Inc. Summary of Key Data Presented at the 2019 Annual Meeting of the American Association for Cancer Research (AACR)

author_avatar
NASDAQ Market News

REPEAT – Tetra Bio-Pharma Announces Pricing of Marketed Public Offering of Units

author_avatar
NASDAQ Market News